Skip to main content
Punita Gupta, MD, Medical Genetics, Paterson, NJ

Punita Gupta MD

Clinical Genetics


Clinical Assistant Professor of Pediatrics NYMC, Chief Division of Genetics, Medical Director Lysosomal Storage Disease Center, Co-Medical Director Alfiero & Lucia Palestroni Center, St. Joseph’s Children’s Hospital

Join to View Full Profile
  • St. Joseph's University Medical Center703 Main St.Paterson, NJ 07503

  • Phone+1 973-754-2727

Dr. Gupta is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineFellowship, Neurogenetics, 2012 - 2013
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Medical Genetics and Genomics, 2010 - 2012
  • University of Illinois College of Medicine at Chicago
    University of Illinois College of Medicine at ChicagoResidency, Pediatrics, 2007 - 2010
  • M.S. Ramaiah Medical College
    M.S. Ramaiah Medical CollegeClass of 2002

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2013 - 2025
  • NY State Medical License
    NY State Medical License 2012 - 2014
  • IL State Medical License
    IL State Medical License 2007 - 2011
  • Pediatrics
    American Board of Pediatrics Pediatrics
  • Clinical Genetics and Genomics
    American Board of Medical Genetics and Genomics Clinical Genetics and Genomics

Publications & Presentations

PubMed

Press Mentions

  • Transforming the Clinical Outcome in CRIM-Negative Infantile Pompe Disease Identified via Newborn Screening: The Benefits of Early Treatment with Enzyme Replacement Therapy and Immune Tolerance Induction
    Transforming the Clinical Outcome in CRIM-Negative Infantile Pompe Disease Identified via Newborn Screening: The Benefits of Early Treatment with Enzyme Replacement Therapy and Immune Tolerance InductionJanuary 25th, 2021

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: